Only about a third of American girls--and less than 7 percent of boys--received the vaccine against human papillomavirus, or HPV, in 2012, a number that is too low for what public health officials had hoped would take hold when the vaccine was first introduced. This is the finding of a report from the President's Cancer Panel, which urged action to improve vaccination rates in order to prevent cervical, vaginal, anal, and some oral cancers.
Among other recommendations, the panel suggests that pharmacists be allowed to administer the vaccines, and that pediatricians be proactive in recommending the vaccine to patients.
The panel's report has slightly different data from earlier findings, such as one report from the CDC that 1 in 5 boys are receiving the vaccine, and another CDC report, released in 2013, that said half of girls receive the vaccine.
The vaccine was first recommended for girls ages 11 and 12 beginning in 2006, and then recommended for boys in 2011.
Help your family get healthier in 12 short weeks with our program.